tradingkey.logo

Haemonetics Corp

HAE
View Detailed Chart

74.770USD

+0.720+0.97%
Close 08/01, 16:00ETQuotes delayed by 15 min
3.61BMarket Cap
21.50P/E TTM

Haemonetics Corp

74.770

+0.720+0.97%
Intraday
1m
30m
1h
D
W
M
D

Today

+0.97%

5 Days

-0.57%

1 Month

-2.73%

6 Months

+13.03%

Year to Date

-4.24%

1 Year

-16.78%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 11 analysts
BUY
Current Rating
93.200
Target Price
24.65%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

117
Total
6
Median
8
Average
Company name
Ratings
Analysts
Haemonetics Corp
HAE
11
Medtronic PLC
MDT
35
Stryker Corp
SYK
33
Abbott Laboratories
ABT
31
Zimmer Biomet Holdings Inc
ZBH
30
Dexcom Inc
DXCM
28
1
2
3
...
24

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Neutral
Sell(5)
Neutral(3)
Buy(5)
Indicators
Sell(3)
Neutral(3)
Buy(1)
Indicators
Value
Direction
MACD(12,26,9)
-0.403
Neutral
RSI(14)
52.509
Neutral
STOCH(KDJ)(9,3,3)
53.679
Sell
ATR(14)
1.769
Low Volatility
CCI(14)
-6.231
Neutral
Williams %R
43.187
Buy
TRIX(12,20)
0.076
Sell
StochRSI(14)
35.484
Sell
Moving Average
Sell(2)
Neutral(0)
Buy(4)
Indicators
Value
Direction
MA5
74.974
Sell
MA10
74.687
Buy
MA20
75.044
Sell
MA50
72.563
Buy
MA100
68.067
Buy
MA200
71.815
Buy

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Haemonetics Corporation is a global healthcare company. The Company is engaged in providing a suite of medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. The Company’s technology addresses various medical markets, including blood and plasma component collection, the surgical suite, and hospital transfusion services. The Company’s Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions sold to plasma customers. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. The Company’s Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies, which includes Hemostasis Management, Cell Salvage and Transfusion Management products.
Ticker SymbolHAE
CompanyHaemonetics Corp
CEOMr. Christopher A. Simon
Websitehttps://www.haemonetics.com
KeyAI